Skip to main content

Table 2 Clinical and laboratory characteristics according to the monocyte-to-HDL ratio quartiles

From: Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention

Parameters Q1(≤0.19)
N = 167
Q2(0.19–0.33)
N = 177
Q3(0.33–0.53)
N = 158
Q4(> 0.53)
N = 171
P
Age(years) 57 ± 11 58 ± 11 60 ± 11 59 ± 11 0.045
Male sex [n (%)] 120(71.9%) 144(81.8%) 130(82.3%) 149(87.3%) 0.004
Smoking [n (%)] 69(41.3%) 84(47.5%) 82(51.9%) 80(46.8%) 0.297
Alcohol intake [n (%)] 54(32.3%) 62(35.0%) 69(43.7%) 66(38.6%) 0.171
Hypertension [n (%)] 74(44.3%) 82(46.3%) 80(50.6%) 87(50.9%) 0.551
Family history of CAD [n (%)] 34(20.4%) 38(21.5%) 34(21.5%) 39(22.8%) 0.960
Hypercholesterolemia[n (%)] 65(38.9%) 70(39.5%) 76(48.1%) 76(44.4%) 0.286
Diabetes [n (%)] 41(24.6%) 44(24.9%) 40(25.3%) 45(26.3%) 0.984
LVEF (%) 61 ± 7 62 ± 7 61 ± 7 61 ± 8 0.401
Gensini score 43 ± 43 45 ± 42 46 ± 37 52 ± 35 0.150
Laboratory parameters
 SBP (mmHg) 130 ± 21 131 ± 24 135 ± 29 139 ± 29 0.003
 HR (bpm) 73 ± 9 74 ± 10 75 ± 11 76 ± 10 0.068
 WBC(×109/l) 6.73 ± 2.14 7.36 ± 1.88 7.58 ± 2.43 8.28 ± 2.58 < 0.001
 MO(×109/l) 0.36 ± 0.05 0.51 ± 0.18 0.54 ± 0.22 0.67 ± 0.23 < 0.001
 HB(× 1012/l) 141 ± 14 140 ± 16 139 ± 15 139 ± 14 0.499
 RDW(%) 13.21 ± 0.98 13.17 ± 0.79 13.15 ± 0.81 13.24 ± 0.20 0.778
 PLT(×109/l) 212 ± 59 217 ± 72 211 ± 61 212 ± 61 0.847
 BUN(mmol/l) 5.49 ± 1.41 5.53 ± 1.63 5.40 ± 1.66 5.40 ± 1.70 0.823
 FBG(mmol/l) 6.15 ± 2.55 6.27 ± 2.51 6.54 ± 3.03 6.93 ± 2.91 0.045
 TG(mmol/l) 2.12 ± 1.25 1.87 ± 1.23 1.87 ± 1.15 2.37 ± 1.70 0.001
 TC(mmol/l) 4.53 ± 1.06 3.97 ± 1.09 3.93 ± 1.46 3.73 ± 1.07 < 0.001
 HDL-C(mmol/l) 2.89 ± 0.95 2.05 ± 0.78 1.31 ± 0.51 0.86 ± 0.30 < 0.001
 LDL-C(mmol/l) 1.27 ± 0.50 1.51 ± 0.98 1.97 ± 1.10 2.14 ± 0.97 < 0.001
 MHR 0.12 ± 0.05 0.25 ± 0.04 0.42 ± 0.06 0.82 ± 0.31 < 0.001
 IBIl(umol/l) 8.57 ± 4.43 9.21 ± 5.52 8.89 ± 5.22 8.26 ± 4.56 0.318
 DBIL(umol/l) 3.17 ± 2.02 3.51 ± 2.28 3.45 ± 2.59 3.10 ± 2.34 0.270
Drugs parameters
 Regular drugs taking 142(85%) 153(86.4%) 143(90.5%) 156(91.2%) 0.215
Clinical result
 Follow up time(m) 45 ± 26 45 ± 29 37 ± 25 31 ± 16 < 0.001
 ACM [n (%)] 1(0.6%) 1(0.6%) 4(2.5%) 8(4.7%) 0.022
 MACE [n (%)] 15(9%) 26(14.7%) 28(17.7%) 33(19.3%) 0.044
  1. Mo Monocyte, PLT Platelet, BUN Blood urea nitrogen, HB Hemoglobin B, FBG Fasting blood glucose, RDW Red cell distribution width, IBil Indirect bilirubin, DBIL Direct bilirubin, ACM All-cause mortality, MACE Major adverse cardiac events